Immunotherapy (such as cytokine therapy, immune checkpoint blocking and car-t cell therapy) has enriched the treatment methods of patients with blood tumors and improved the prognosis. With the increasing attention to the unique characteristics and specific cytotoxicity of NK cells, the research focus has shifted from T cells to NK cells.NK cells belong to the innate lymphocyte family and are a cl···

Cytokine storm syndrome (CSS) is now common in viral infections such as Xinguan, immunotherapy such as car-t (chimeric antigen receptor T cell immunotherapy), and autoimmune diseases such as hemophagocytic lymphohistiocytosis, which can cause tissue damage and systemic multiple organ failure, resulting in serious consequences. Infection induced cytokine storm Infection related cytokines or sepsis ···

On October 9, 2021, during the 16th National leukemia and lymphoma academic conference of Chinese Medical Association, the Yaoming junuo Satellite Conference co chaired by Professor Qiu lugui of Hematology Hospital of Chinese Academy of Medical Sciences and Professor Niu Ting of West China Hospital of Sichuan University was successfully held. During the satellite meeting, Professor Wang Li of Ruij···

Chimeric antigen receptor T cell (car-t) therapy has been widely used in the treatment of various types of recurrent / refractory (R / R) B-cell malignant tumors. At present, five car-t products have been approved by the U.S. Food and Drug Administration (FDA). Tisagenelecluel, axicabatagene ciloleucel and liscabatagene maraluel are three kinds of treatment for R / R diffuse large B-cell lymphoma ···